Phenylephrine Versus Norepinephrine for Maintenance of Hemodynamic During Cesarean Section Under Spinal Anesthesia

PHASE4CompletedINTERVENTIONAL
Enrollment

124

Participants

Timeline

Start Date

February 27, 2019

Primary Completion Date

December 2, 2020

Study Completion Date

December 2, 2020

Conditions
Cesarean Section ComplicationsSpinal Anesthesia
Interventions
DRUG

Norepinephrine

"Drug: Norepinephrine Norepinephrine tartrate variable infusion with a starting rate of 0,1μg/kg/min (equivalent to norepinephrine base of 0.05 μg /Kg/min).~Other name: Noradrenaline~Drug: Hyperbaric Bupivacaine will be injected in the subarachnoid space with a dose of 8 to 12 mg adjusted according to height~Drug: Sufentanil will be injected in the subarachnoid space with a dose of 2,5μg~Drug: Morphine will be injected in the subarachnoid space with a dose of 100 μg"

DRUG

Phenylephrine

"Drug: Phenylephrine variable infusion with a starting rate of 0,5μg/kg/min~Drug: Hyperbaric Bupivacaine will be injected in the subarachnoid space with a dose of 8 to 12 mg adjusted according to height~Drug: Sufentanil will be injected in the subarachnoid space with a dose of 2,5μg~Drug: Morphine will be injected in the subarachnoid space with a dose of 100 μg"

Trial Locations (1)

45067

Regional Hospital Center of ORLEANS, Orléans

All Listed Sponsors
lead

Centre Hospitalier Régional d'Orléans

OTHER

NCT03849508 - Phenylephrine Versus Norepinephrine for Maintenance of Hemodynamic During Cesarean Section Under Spinal Anesthesia | Biotech Hunter | Biotech Hunter